Clinical trials
Enrolling by invitation Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 7 |
| 2024 | 13 |
| 2025 | 22 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 62 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Indiana University | 2 |
| Linkoeping University | 2 |
| NYU Langone Health | 2 |
| Rutgers, The State University of New Jersey | 2 |
| Shanghai Golden Leaf MedTec Co. Ltd | 2 |
| Truway Health, Inc. | 2 |
| University of California, San Francisco | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Ain Shams University | 1 |
| Bangladesh University of Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 62 |
| Diabetes Mellitus | 13 |
| Cardiovascular Diseases | 8 |
| Diabetes Mellitus, Type 2 | 8 |
| Obesity | 7 |
| Overweight | 7 |
| Renal Insufficiency, Chronic | 6 |
| Heart Failure | 5 |
| Hyperlipidemias | 5 |
| Atrial Fibrillation | 4 |
Trials
Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.